Stockscreener 앱 받기
135.50
1.26%
1.68
시간 외 거래:
135.12
-0.38
-0.28%
전일 마감가:
$133.82
열려 있는:
$135.33
하루 거래량:
814.53K
Relative Volume:
1.10
시가총액:
$4.63B
수익:
$531.29M
순이익/손실:
$71.66M
주가수익비율:
70.07
EPS:
1.9338
순현금흐름:
$17.35M
1주 성능:
+1.65%
1개월 성능:
-5.49%
6개월 성능:
+7.84%
1년 성능:
+80.62%
1일 변동 폭
$132.78
$136.41
1주일 범위
$127.50
$137.49
52주 변동 폭
$62.07
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
135.50 | 4.57B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 업그레이드 | Needham | Hold → Buy |
| 2025-10-13 | 개시 | Jefferies | Buy |
| 2025-09-16 | 개시 | Evercore ISI | Outperform |
| 2025-09-04 | 개시 | Stifel | Hold |
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
The Bull Case For TransMedics Group (TMDX) Could Change Following Full FDA Approval Of ENHANCE Heart Trial - Yahoo Finance
A Look At TransMedics Group (TMDX) Valuation After Full FDA Approval For Next Generation OCS Heart Trial - Yahoo Finance
What Catalysts Are Reframing The TransMedics Group (TMDX) Narrative Now - Yahoo Finance
FDA Greenlights TransMedics ENHANCE Heart Trial Shaping Growth Prospects - Yahoo Finance
How to watch TransMedics' March investor events online - Stock Titan
TransMedics Group (TMDX) to Release Quarterly Earnings on Tuesday - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking a 11% Upside in the Medical Device Sector - DirectorsTalk Interviews
Understanding the Setup: (TMDX) and Scalable Risk - Stock Traders Daily
TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial - Zacks Investment Research
Bastion Asset Management Inc. Purchases New Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Inc (NASDAQ:TMDX) Screened as a High-Momentum Growth Stock - ChartMill
Public Sector Pension Investment Board Raises Position in TransMedics Group, Inc. $TMDX - MarketBeat
How Investors May Respond To TransMedics Group (TMDX) Full IDE Approval For ENHANCE Heart Trial - simplywall.st
Wall Street Zen Upgrades TransMedics Group (NASDAQ:TMDX) to Buy - MarketBeat
Will TransMedics Group Inc. outperform the market in YEARBuy Signal & Weekly High Potential Stock Alerts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Now An Opportune Moment To Examine TransMedics Group, Inc. (NASDAQ:TMDX)? - Yahoo Finance
How Do Investors Really Feel About TransMedics Group Inc? - Benzinga
Big Money Moves: What makes TransMedics Group Inc stock attractive todayMarket Rally & Fast Exit and Entry Trade Guides - baoquankhu1.vn
What Is TransMedics Group, Inc.'s (NASDAQ:TMDX) Share Price Doing? - 富途牛牛
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Sahm
TransMedics receives full FDA approval for heart transplant trial - Investing.com Nigeria
TransMedics receives full FDA approval for heart transplant trial By Investing.com - Investing.com Australia
TransMedics (TMDX) Secures FDA Approval for Advanced Heart Device Trial - GuruFocus
TransMedics receives full and unconditional FDA IDE approval for next-generation OCS Heart Enhance trial - marketscreener.com
TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead - Stock Titan
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial - Sahm
New York State Common Retirement Fund Sells 134,406 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
Seaport Research to Host Virtual Meeting Focusing on TMDX - GuruFocus
Renaissance Group LLC Acquires Shares of 76,078 TransMedics Group, Inc. $TMDX - MarketBeat
Principal Financial Group Inc. Purchases 53,995 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TD Cowen Sticks to Its Buy Rating for TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group Names New Commercial Leader - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
Commit To Buy TransMedics Group At $80, Earn 16.2% Using Options - Nasdaq
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), UnitedHealth (UNH) and Johnson & Johnson (JNJ) - The Globe and Mail
TransMedics Group Inc (NASDAQ:TMDX): A GARP Stock with Strong Growth at a Fair Price - ChartMill
Up 95% In Last 12 Months, Can TransMedics Stock Keep Climbing In 2026? - TIKR.com
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Finviz
Brown Capital Management LLC Reduces Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics: Italian NOP Program Reinforces Huge International Opportunity (NASDAQ:TMDX) - Seeking Alpha
Reasons to retain TransMedics stock in your portfolio for now - MSN
TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential Amidst Robust Revenue Surge In Medical Devices - DirectorsTalk Interviews
These 10 Stocks Could Be Short Squeeze Targets: Lucid, Kohl's, Avis and More - Benzinga
TransMedics Group Inc (NASDAQ:TMDX) Shows Strong Growth Momentum and Technical Setup - ChartMill
Lisanti Capital Growth LLC Grows Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Growth with Bullish Technical Momentum - ChartMill
TransMedics Group (NASDAQ:TMDX) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
TransMedics Group Inc (TMDX) Shares Gap Down to $133.5 on Jan 30 - GuruFocus
Assessing TransMedics Group (TMDX) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
자본화:
|
볼륨(24시간):